CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 729 enrolled
Drug / intervention
Influenza virus vaccine - cell based (2007-2008 Formulation) +2 morebiological
Likely dose
Influenza virus vaccine - cell based (2007-2008 Formulation) 0.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00845429
NCT00845429Phase 2Completed
CompareCT.gov

Immunogenicity of Two Dosages of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine Administered in Healthy Adult Subjects Aged 18 to 49 Years

Sanofi·interventional·Posted Feb 18, 2009·Updated Dec 19, 2012

In Brief

A Phase 2 clinical trial evaluating Influenza virus vaccine - cell based (2007-2008 Formulation), Influenza virus vaccine - cell-based (2007-2008 Formulation), and 1 other intervention for Influenza and 2 related conditions. Completed, enrolled 729 participants across 15 sites.

Detailed Summary

Primary Objective: To describe the immune response to a single administration of 2 formulations of the investigational cell-based influenza vaccines in healthy adult subjects. Secondary Objective: To describe the safety following a single administration of 2 formulations of the investigational cell-based influenza vaccines in healthy adult subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza, Orthomyxoviruses, Myxovirus Infection
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 18, 2009
Enrollment StartOct 1, 2007
Primary CompletionAug 1, 2008
Study CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.4 years ago

Interventions

Influenza virus vaccine - cell based (2007-2008 Formulation)biological

0.5 mL, Intramuscular

Influenza virus vaccine - cell-based (2007-2008 Formulation)biological

1.0 mL, Intramuscular

Influenza virus vaccine (2007-2008 Formulation)biological

0.5 mL, Intramuscular